STAT

Opinion: Covid-19 will be the ultimate stress test for electronic health record systems

Just as the levees of New Orleans stood little chance against the wrath of Hurricane Katrina, our overly complex, inflexible, noninteroperable, and often off-purpose electronic health record systems aren’t ready for an average Sunday afternoon, let alone Covid-19.

As the novel coronavirus that causes Covid-19 continues its march around the world and through the United States, it is spawning another kind of infection: Covid-19 cyber threats aimed at individuals and health systems.

We aren’t crying wolf here. Disaster planning experts know all too well that preexisting weaknesses become worse during crises. The WannaCry cyber attack that devastated the United Kingdom’s National Health Service is a good example. Outdated infrastructure containing components with long-understood vulnerabilities are a hacker’s paradise.

But here’s the silver lining: Because the weaknesses are well-known, health systems can plan for them and around them.

Functionality and usability

The undeniable fact that electronic health record systems are designed to rather than provide optimal patient

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min readIntelligence (AI) & Semantics
STAT+: Q&A: Defining Responsible AI In Health Care, With CHAI CEO Brian Anderson
CHAI CEO Anderson wants to build public trust in AI and empower patients and providers to have more informed conversations.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Approval For Sarepta Drug, MSF Closing Access Campaign And More
After months of haggling, Vertex Pharmaceuticals and the National Health Service in England reached agreement over access to several cystic fibrosis treatments, capping an end to a controversial, long-running saga:
STAT2 min read
STAT+: Pharmalittle: We’re Reading About EMA Plans For GLP-1 Shortages, Walgreens Store Closings, And More
The European Medicines Agency and member countries announced several steps to address shortages of GLP-1 drugs.

Related Books & Audiobooks